Genetic Studies Reveal Europe has at least Four Distinct Population Groups

Studies of the regions of Y chromosome that are inherited together (haplogroups), reveal Europe has four population groups, namely R1b-M269, I1-M253, I2-M438 and R1a-M420, pointing to four distinct paternal origins. R1b-M269 group is the most common group that is present in countries of Wales, Ireland, England, Germany, Spain, Netherlands, France and Poland while I1-M253 has its origins in Northern Europe and is predominantly found today in countries of Sweden, Finland, Denmark, Iceland, and Norway. I2-M438 has its origins in Southern and Eastern and is predominantly found today in Sicily, Celtec, Bosnia, Herzegovina and Switzerland. The R1a-M420 group has its origins in Eurasia and South West Asia around 25000 years ago. Another genetically distinct population group is of Roma people belonging to haplogroup H1a1a-M82, has its origins in the north-western region of the Indian sub-continent 

European continent has seen a number of infightings and migrations. With the result, the continent has been described as turning into a melting pot with populations of various origins and cultures living and thriving together. In order to understand the paternal origins of the populations living in Europe today, it is helpful to study Y chromosome variability and how it contributes to the distribution and development of male genetic pool. Studies on the polymorphism of the Y chromosome show the presence of four major haplogroups, namely R1b-M269, I1-M253, I2-M438 and R1a-M4201.  

R1b-M269 group is the most common group that originated around 4000-10000 years ago in Basque region of France and Spain2 and is present in ~110 million European men. It is present in countries of Wales, Ireland, England, Germany, Spain, Netherlands, France and Poland and increases in frequency on an east to west gradient, its prevalence in Poland at 22.7%, compared to Wales at 92.3%. Interestingly, this haplotype has been associated with different European colonisations, mainly in several American countries. 

I1-M253 has its origins in Northern Europe around 5070 years ago and is predominantly found today in countries of Sweden, Finland, Denmark, Iceland, Norway.  

I2-M438 has its origins in Southern and Eastern Europe around 33000 years ago and is predominantly found today in Sicily, Celtec, Bosnia, Herzegovina and Switzerland. 

R1a-M420 has its origins in Eurasia and South West Asia around 25000 years ago, and is currently found in populations extending from Scandinavia and Central Europe to southern Siberia and South Asia. 

Another European population group with haplogroup on Y chromosome of H1a1a-M823, comprising 10—12 million people, concentrated mainly in Eastern and Central European region such as Romania, Bulgaria, Hungary etc. at present, had its origin in north-western region of Indian sub-continent. These people are known as Roma4 people. 

Thus, in spite of migrations, European population comes across as having these genetically distinct groups based on haplotypes, that have maintained their paternal identity. 

*** 

References:  

  1. Navarro-López B, Granizo-Rodríguez E, Palencia-Madrid L et al. Phylogeographic review of Y chromosome haplogroups in Europe. Int J Legal Med 135, 1675–1684 (2021). DOI: https://doi.org/10.1007/s00414-021-02644-6 
  1. Lucotte G. The Major Y-Chromosome Haplogroup R1b-M269 in West-Europe, subdivided by the Three SNPs S21/U106, S145/L21 and S28/U152, Shows a Clear Pattern of Geographic Differentiation. Advances in Anthropology, 5, 22-30 (2015). DOI: https://doi.org/10.4236/aa.2015.51003
  1. Rai N, Chaubey G, Tamang R, et al. The Phylogeography of Y-Chromosome Haplogroup H1a1a-M82 Reveals the Likely Indian Origin of the European Romani Populations. PLoS ONE 7(11): e48477 (2012). DOI: https://doi.org/10.1371/journal.pone.0048477 
  1. Jayaraman K S. European Romanis came from northwest India. Nature India (2012). DOI: https://doi.org/10.1038/nindia.2012.179 

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

New Understanding of Schizophrenia

A recent breakthrough study unearths anew mechanism of schizophrenia....

Closest Ever Images of the Sun    

Parker Solar Probe (PSP) made in-situ data collection and...

The Possible Cure of Type 2 Diabetes?

The Lancet study shows that Type 2 diabetes can...

Immortality: Uploading Human Mind to Computers?!

The ambitious mission of replicating the human brain onto...

mRNA-1273: Moderna Inc.’s mRNA Vaccine Against Novel Coronavirus Shows Positive Results

A biotech firm, Moderna, Inc. has announced that ‘mRNA-1273’,...

Mobile Phone Use Not Linked to Brain Cancer 

The radiofrequency (RF) exposure from mobile phones was not associated...
Rajeev Soni
Rajeev Sonihttps://web.archive.org/web/20220523060124/https://www.rajeevsoni.org/publications/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...